For a Limited Time: Get 3 Years of Access at the Price of 1
Here is the latest financial fact sheet of IND SWIFT LA. For more details, see the IND SWIFT LA quarterly results and IND SWIFT LA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 2.3 |
No. of shares | m | 59.09 |
1 Week | % | -12.3 |
1 Month | % | -17.8 |
1 Year | % | 66.9 |
52 week H/L | Rs | 138.3/63.4 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
IND SWIFT LA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 111 | 48 | 90 | 127 | 77 | |
Low | Rs | 39 | 15 | 20 | 56 | 51 | |
Sales per share (Unadj.) | Rs | 159.1 | 131.9 | 150.8 | 175.8 | 204.3 | |
Earnings per share (Unadj.) | Rs | 6.1 | -3.6 | -0.5 | -0.4 | 8.1 | |
Diluted earnings per share | Rs | 4.9 | -3.6 | -0.5 | -0.4 | 8.1 | |
Cash flow per share (Unadj.) | Rs | 28.0 | 11.7 | 14.2 | 21.8 | 17.8 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 123.6 | 108.4 | 102.1 | 101.7 | 115.4 | |
Adj. book value per share | Rs | 99.5 | 108.4 | 102.1 | 101.7 | 115.4 | |
Shares outstanding (eoy) | m | 47.57 | 59.09 | 59.09 | 59.09 | 59.09 | |
Price / Sales ratio | x | 0.5 | 0.2 | 0.4 | 0.5 | 0.3 | |
Avg P/E ratio | x | 12.3 | -8.8 | -103.4 | -252.1 | 7.9 | |
P/CF ratio (eoy) | x | 2.7 | 2.7 | 3.9 | 4.2 | 3.6 | |
Price / Book Value ratio | x | 0.6 | 0.3 | 0.5 | 0.9 | 0.6 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 3,564 | 1,857 | 3,254 | 5,417 | 3,785 | |
Total wages/salary | Rs m | 910 | 959 | 979 | 1,174 | 1,262 |
IND SWIFT LA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 7,566 | 7,796 | 8,913 | 10,387 | 12,073 | |
Other income | Rs m | 369 | 335 | 227 | 435 | 335 | |
Total revenues | Rs m | 7,935 | 8,131 | 9,141 | 10,822 | 12,408 | |
Gross profit | Rs m | 2,091 | 1,435 | 1,828 | 1,956 | 2,026 | |
Depreciation | Rs m | 1,040 | 901 | 873 | 1,310 | 574 | |
Interest | Rs m | 922 | 1,067 | 1,002 | 955 | 922 | |
Profit before tax | Rs m | 497 | -198 | 180 | 125 | 865 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 207 | 14 | 212 | 147 | 387 | |
Profit after tax | Rs m | 289 | -212 | -31 | -21 | 478 | |
Gross profit margin | % | 27.6 | 18.4 | 20.5 | 18.8 | 16.8 | |
Effective tax rate | % | 41.7 | -7.2 | 117.5 | 117.2 | 44.7 | |
Net profit margin | % | 3.8 | -2.7 | -0.4 | -0.2 | 4.0 |
IND SWIFT LA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 8,361 | 8,630 | 9,419 | 10,733 | 11,631 | |
Current liabilities | Rs m | 3,560 | 3,231 | 3,145 | 3,345 | 3,711 | |
Net working cap to sales | % | 63.5 | 69.3 | 70.4 | 71.1 | 65.6 | |
Current ratio | x | 2.3 | 2.7 | 3.0 | 3.2 | 3.1 | |
Inventory Days | Days | 42 | 35 | 17 | 12 | 10 | |
Debtors Days | Days | 1,693 | 1,856 | 1,771 | 1,598 | 1,528 | |
Net fixed assets | Rs m | 10,091 | 9,290 | 8,139 | 6,736 | 6,297 | |
Share capital | Rs m | 483 | 598 | 598 | 598 | 598 | |
"Free" reserves | Rs m | 5,395 | 5,808 | 5,437 | 5,412 | 6,221 | |
Net worth | Rs m | 5,878 | 6,406 | 6,035 | 6,010 | 6,819 | |
Long term debt | Rs m | 9,656 | 8,909 | 8,841 | 8,478 | 7,526 | |
Total assets | Rs m | 18,451 | 17,920 | 17,581 | 17,489 | 17,942 | |
Interest coverage | x | 1.5 | 0.8 | 1.2 | 1.1 | 1.9 | |
Debt to equity ratio | x | 1.6 | 1.4 | 1.5 | 1.4 | 1.1 | |
Sales to assets ratio | x | 0.4 | 0.4 | 0.5 | 0.6 | 0.7 | |
Return on assets | % | 6.6 | 4.8 | 5.5 | 5.3 | 7.8 | |
Return on equity | % | 4.9 | -3.3 | -0.5 | -0.4 | 7.0 | |
Return on capital | % | 9.1 | 5.7 | 7.9 | 7.5 | 12.5 | |
Exports to sales | % | 63.5 | 67.3 | 71.5 | 71.7 | 73.4 | |
Imports to sales | % | 22.9 | 25.0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 4,805 | 5,250 | 6,377 | 7,453 | 8,859 | |
Imports (cif) | Rs m | 1,729 | 1,948 | 0 | 0 | 0 | |
Fx inflow | Rs m | 4,906 | 5,250 | 6,377 | 7,454 | 8,859 | |
Fx outflow | Rs m | 1,888 | 2,131 | 116 | 194 | 285 | |
Net fx | Rs m | 3,018 | 3,118 | 6,261 | 7,260 | 8,574 |
IND SWIFT LA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -644 | 1,252 | 1,349 | 1,503 | 1,946 | |
From Investments | Rs m | -125 | -91 | -102 | 48 | -134 | |
From Financial Activity | Rs m | 996 | -1,333 | -1,237 | -1,409 | -1,857 | |
Net Cashflow | Rs m | 205 | -194 | 10 | 142 | -44 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: N R Munjal | COMP SEC: Pardeep Verma | YEAR OF INC: 1995 | BSE CODE: 532305 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare IND SWIFT LA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
On Friday, Indian share markets traded on a positive note throughout the trading session and ended higher.